Breaking News Headlines Today | Ground News

See every side of every news story

Eyewire+ image

News from Eyewire+

Eyewire+’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

Eyewire+’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Eyewire+

Where is Eyewire+ located?Eyewire+'s Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Eyewire+ News

Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Replacement Contact Lens to Start and End Every Week Fresh

Innovation · Toronto

Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Replacement Contact Lens to Start and End Every Week Fresh

Coverage: 2 sources

TORONTO--(BUSINESS WIRE)--Feb 2, 2026-See the Story

STAAR Names Interim Co-CEOs Amid Search for Permanent Leader

STAAR Names Interim Co-CEOs Amid Search for Permanent Leader

100% Center coverage: 1 sources

The company is searching for a new leader after former CEO Stephen Farrell left when STAAR shareholders rejected a buyout offer from Alcon.See the Story

Everyday diabetes medicine could treat common cause of blindness

Everyday diabetes medicine could treat common cause of blindness

100% Center coverage: 1 sources

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the most common cause of blindness in western countries. In a recent study, people with diabetes over the age of 55 years taking metformin were 37% less likely to develop the intermediate stage of AMD over a five-year period compared to those not taking metformin.See the Story

Breaking News Topics Related to Eyewire+